GlassScriptPhysician profile
Kirk A Reynolds
NPI 1013118025
$18,258.24
in general payments reported to CMS, 2019-2025
15 companies · $1,969 in 2025
The $1,969 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,416 · 2020: $4,694 · 2021: $4,352 · 2022: $194 · 2023: $595 · 2024: $2,038 · 2025: $1,969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,721 · Consulting Fee: $1,500 · Travel and Lodging: $1,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,720.83 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $1,381.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $9,841.82 | 2019-2021 | |
| Midsouth Orthopedics INC. | $2,894.28 | 2019-2024 | |
| Stryker Corporation | $2,391.78 | 2022-2025 | Blueprint Patient Specific Instrumentation, 1688, Crossfire |
| Ossio INC | $1,500.00 | 2024 | |
| Smith+Nephew, INC. | $406.95 | 2019-2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Zimmer Biomet Holdings, INC. | $270.64 | 2023-2025 | Comprehensive Shoulder System |
| Pacira Pharmaceuticals Incorporated | $206.64 | 2022-2023 | Exparel, Iovera, Zilretta |
| Ossur Americas, INC. | $199.17 | 2024 | Miami J |
| Depuy Synthes Sales INC. | $187.38 | 2019-2025 | |
| Integra Lifesciences Corporation | $152.23 | 2020-2024 | Tenoglide |
| Baudax Bio INC. | $54.19 | 2021 | |
| Catalyst Orthoscience | $54.07 | 2021 | |
| Horizon Therapeutics Plc | $44.44 | 2021 | |
| Bioventus LLC | $35.40 | 2020-2023 | Durolane |
| Vertex Pharmaceuticals Incorporated | $19.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Reynolds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.